When Jim Cramer showed up at the New York Stock Exchange on Friday morning and saw a line of media trucks sitting out front, he knew the market would be in panic. Historically, he only sees news trucks appear when there is a panic, typically after the bottom of a big decline the day before.

By the end of the day, the Dow Jones industrial average closed down more than 600 points. What was strange to Cramer, though, was that the U.S. market was down worse than the U.K. How the heck could that be possible if only a handful of Americans actually have significant exposure to the U.K.?

The first reason was that the market hates surprises, and this one was nasty. The night before, all numbers told Cramer that the market would be able to handle it. Yet, by the morning the futures were down big.

Soon there was speculation of what country would be next to leave the EU.

"I think that's a bit of a straw man. Now that we see the impact in our faces, the pain that comes from the next exit vote will be entirely predictable, even if there is one, which I doubt," Cramer said.

Cramer expects the market to head lower next week as investors realize that the consequences of a Brexit could be severe.

In Cramer's perspective, the U.K. already had one foot out the door, which is why he didn't think a Brexit was the end of the world. Britain already had its own currency, and it could take years to actually leave the EU.

"It is still a big deal because we haven't had time to sort through the ramifications of this pro-Brexit vote. Ramifications that can explain the gigantic declines we just saw in the stocks of the major European banks," Cramer said.

Next week, Cramer will be on the hunt for ideal tech and health care plays that don't have a lot of exposure to Europe. He thinks many analysts are ready to revise down the earnings estimates of companies that do a lot of business not only in the U.K., but in Europe. There is a real possibility that Europe could fall into a recession, Cramer said.

"Let's not be glib. I am not worried about systematic risk here. Our banks have never been stronger; our companies are flush with cash. The world will grow more slowly than it is now, but our companies will be ready for that. The United States will be the safe haven," Cramer said.

But even before the U.K. voted to leave the European Union, he was suspicious about stocks.

"I am a calculated risk dip-buyer, willing to pick up stocks into weakness and make a stand. So why not be aggressive right here? I'll tell you why—earnings," Cramer said.

As Cramer expects the market to continue to be hammered next week, he will be on the lookout for cheap technology stocks with a big dividend, like Cisco Systems.

Chuck Robbins took over as CEO a little less than a year ago, and has been transforming the company into key growth areas such as internet of things, cybersecurity and the data center. Cramer spoke with Robbins on how the recent volatility overseas could impact the company.

"The U.K. itself represents mid-single digits for us from a business perspective. We obviously are committed to the U.K. and other countries in Europe from a digitization perspective regardless of what transpires here. Our focus is on the things that we can control," Robbins said.

Another company Cramer highlighted was Red Hat, the No. 1 provider of Linux based open-source operating systems for enterprise. It also covers middleware, virtualization, storage software and cloud business.

Cramer spoke with Red Hat's President and CEO Jim Whitehurst on its recent partnership with BBVA, and how the Brexit vote could impact the company.

"Red Hat is known for providing cloud and kind of next generation IT solutions for enterprises around the world. About 25 percent of our business is in Europe," Whitehurst said.

In the Lightning Round, Cramer gave his take a few caller favorite stocks:

Monster Beverage: "Monster Beverage had a really good quarter. I think they're doing incredibly well, but they have a big business in Europe so people are going to freak out. I think under $150 it's getting interesting. Not yet though."

Alnylam Pharmaceuticals: "This is a big speculative stock. Obviously this market abhors speculation, but it's very low. No ... you're going to lose money I believe in that stock. You've just got to wait a little bit."